Another relevant biomarker (selected for all cancer types, Figure 3C) is IRF1. The IRF1 TF can regulate the expression of PD-L150,56 and the production of cytokines, including the CXCL9 chemokine that is responsible for recruiting antitumor immune cells.39 Here, CXCL9 is linked to cancer.